12-Mar-2026
B. Riley Securities Remains a Buy on REPRO-MED Systems (KRMD)
TipRanks (Fri, 13-Mar 8:36 AM ET)
Business Wire (Fri, 13-Mar 8:00 AM ET)
REPRO-MED Systems (KRMD) Gets a Hold from Piper Sandler
TipRanks (Fri, 13-Mar 7:59 AM ET)
Canaccord Genuity Keeps Their Buy Rating on REPRO-MED Systems (KRMD)
TipRanks (Fri, 13-Mar 7:58 AM ET)
Seeking Alpha News (Thu, 12-Mar 7:52 PM ET)
KORU Medical Systems CEO Linda Tharby to retire
Seeking Alpha News (Thu, 12-Mar 4:19 PM ET)
KORU Medical Systems reports Q4 results
Seeking Alpha News (Thu, 12-Mar 4:17 PM ET)
KORU Medical Systems Announces CEO Transition
Business Wire (Thu, 12-Mar 4:08 PM ET)
Business Wire (Thu, 12-Mar 4:05 PM ET)
TipRanks (Thu, 12-Mar 11:40 AM ET)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Koru Medical Systems trades on the NASDAQ stock market under the symbol KRMD.
As of March 12, 2026, KRMD stock price declined to $4.31 with 133,578 million shares trading.
KRMD has a beta of 1.43, meaning it tends to be more sensitive to market movements. KRMD has a correlation of 0.20 to the broad based SPY ETF.
KRMD has a market cap of $199.65 million. This is considered a Micro Cap stock.
Last quarter Koru Medical Systems reported $10 million in Revenue and $.00 earnings per share. This beat revenue expectation by $714,760 and exceeded earnings estimates by $.03.
In the last 3 years, KRMD traded as high as $6.61 and as low as $1.86.
The top ETF exchange traded funds that KRMD belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
KRMD has outperformed the market in the last year with a return of +31.4%, while the SPY ETF gained +20.5%. However, in the most recent history, KRMD shares have underperformed the stock market with its stock returning -25.4% in the last 3 month period and -12.9% for the last 2 week period, while SPY has returned -2.0% and -3.4%, respectively.
KRMD support price is $4.33 and resistance is $4.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KRMD shares will trade within this expected range on the day.